J. Bloomer et al., MOLECULAR DEFECTS IN FERROCHELATASE IN PATIENTS WITH PROTOPORPHYRIA REQUIRING LIVER-TRANSPLANTATION, The Journal of clinical investigation, 102(1), 1998, pp. 107-114
Protoporphyria is a genetic disorder in which a deficiency of mitochon
drial ferrochelatase activity causes accumulation of protoporphyrin th
at produces severe liver damage in some patients. In this study, mutat
ions of the ferrochelatase gene were examined in eight unrelated patie
nts who had liver transplantation. RNA was prepared from liver and/or
lymphoblasts, and specific reverse transcriptase-nested polymerase cha
in reactions amplified and sequenced ferrochelatase cDNAs. Products sh
orter than normal resulted from an exon 3 deletion in three patients,
exon 10 deletion in two, exon 2 deletion in one, and deletion of five
nucleotides in exon 5 in one. Sequence of normal-size products reveale
d no other mutations. Western blot showed a reduced quantity of normal
-size ferrochelatase protein in protoporphyria liver compared with nor
mal liver (19-51%, mean 32% of normal). Levels of the mitochondrial pr
otein F-1-ATPase P-subunit were not decreased to a similar degree. Liv
er ferrochelatase activity was reduced more than could be explained by
the decrease in ferrochelatase protein (4-20%, mean 9% of normal). Th
ese results establish genetic heterogeneity in the most severe phenoty
pe of protoporphyria. However, the gene mutations found share the prop
erty of causing a major structural alteration in the ferrochelatase pr
otein.